Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 201–300 of 942
Palau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F. J., & Andres-Lacueva, C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01151 · Cited by 157
“Recent studies have shown that circulating levels of choline and TMAO are related to cardiovascular disease risk (Dumas et al., 2006; Micha et al., 2010; Wang et al., 2011; Koeth et al., 2013; Warrier et al., 2015), and the gut microbiota-driven TMAFMO3-TMAO pathway has been particularly recognized…”
BackgroundZhang, X., Wang, Y., Hao, F., Zhou, X., Han, X., Tang, H., & Ji, L. (2009) · Journal of Proteome Research · doi:10.1021/pr900524z · Cited by 148
Di Ciaula, A., Baj, J., Garruti, G., Celano, G., De Angelis, M., Wang, H. H., Di Palo, D. M., Bonfrate, L., Wang, D. Q.-H., & Portincasa, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082648 · Cited by 163
Bahr, S. M., Weidemann, B. J., Castro, A. N., Walsh, J. W., deLeon, O., Burnett, C. M. L., Pearson, N. A., Murry, D. J., Grobe, J. L., & Kirby, J. R. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.018 · Cited by 143
“…the diet (Turnbaugh et al., 2006, 2008), modulation of lipid metabolism (Bäckhed et al., 2004; Velagapudi et al., 2010), altered endocrine function (Dumas et al., 2006; Swann et al., 2011;Wang et al., 2011), and inflammatory stability (Elinav et al., 2011; Hall et al., 2011; Henao-Mejia et al.,…”
BackgroundMa, L., Li, H., Hu, J., Zheng, J., Zhou, J., Botchlett, R., Matthews, D., Zeng, T., Chen, L., Xiao, X., et al. (2020) · Hepatology · doi:10.1002/hep.31115 · Cited by 147
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 166
“Indeed, changes in the gut microbiota mimic the effect of a choline-deficient diet, which leads to accumulation of TGs in hepatocytes and reduced VLDL secretion (83).”
BackgroundRiaz Rajoka, M. S., Shi, J., Mehwish, H. M., Zhu, J., Li, Q., Shao, D., Huang, Q., & Yang, H. (2017) · Food Science and Human Wellness · doi:10.1016/j.fshw.2017.07.003 · Cited by 166
The normal intestinal microbiota
Marchesi, J., & Shanahan, F. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a56a99 · Cited by 134
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 149
Characterization of Choline Trimethylamine-Lyase Expands the Chemistry of Glycyl Radical Enzymes
Craciun, S., Marks, J. A., & Balskus, E. P. (2014) · ACS Chemical Biology · doi:10.1021/cb500113p · Cited by 139
The interaction between the gut Microbiota and herbal medicines
An, X., Bao, Q., Di, S., Zhao, Y., Zhao, S., Zhang, H., Lian, F., & Tong, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109252 · Cited by 162
Soy and Gut Microbiota: Interaction and Implication for Human Health
Huang, H., Krishnan, H. B., Pham, Q., Yu, L. L., & Wang, T. T. Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03725 · Cited by 138
Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe −/− Mice
Lindskog Jonsson, A., Caesar, R., Akrami, R., Reinhardt, C., Fåk Hållenius, F., Borén, J., & Bäckhed, F. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311233 · Cited by 151
“Thus suggesting that microbial metabolism of choline may have additional effects on host metabolism in agreement with earlier studies.(34) In agreement with previous findings, we showed that the effect of gut microbiota on atherosclerosis is dietary dependent,(11) and atherosclerotic lesions develop regardless of micr…”
ResultThe human gut microbiome: Implications for future health care
Kinross, J. M., von Roon, A. C., Holmes, E., Darzi, A., & Nicholson, J. K. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0075-y · Cited by 137
Self-citationUshiroda, C., Naito, Y., Takagi, T., Uchiyama, K., Mizushima, K., Higashimura, Y., Yasukawa, Z., Okubo, T., Inoue, R., Honda, A., et al. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-116 · Cited by 159
High-Fat Diet Induces Dynamic Metabolic Alterations in Multiple Biological Matrices of Rats
An, Y., Xu, W., Li, H., Lei, H., Zhang, L., Hao, F., Duan, Y., Yan, X., Zhao, Y., Wu, J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400398b · Cited by 139
Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study
Ji, D., Chen, W.-Z., Zhang, L., Zhang, Z., & Chen, L. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02999-0 · Cited by 164
“The gut microbiome may also play a role in metabolic diseases, such as insulin resistance and fatty liver disease [35].”
BackgroundBiological insights through nontargeted metabolomics
Sévin, D. C., Kuehne, A., Zamboni, N., & Sauer, U. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.001 · Cited by 152
Brial, F., Chilloux, J., Nielsen, T., Vieira‐Silva, S., Falony, G., Andrikopoulos, P., Olanipekun, M. T., Hoyles, L., Djouadi, F., Neves, A. L., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323314 · Cited by 173
Self-citationThe gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
“Its role in choline metabolism [50–52], as well as in activation of pro-inflammatory cytokines (e.”
BackgroundProbiotics and gut health: A special focus on liver diseases
Gratz, S. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.403 · Cited by 123
“The author suggested a contribution of microflora to the development of the NAFLD phenotype [ 54 ]”
BackgroundThe gut microbiome and aquatic toxicology: An emerging concept for environmental health
Adamovský, O., Buerger, A. N., Wormington, A. M., Ector, N., Griffitt, R. J., Bisesi, J. H., & Martyniuk, C. J. (2018) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4249 · Cited by 170
Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Boursier, J., & Diehl, A. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 132
“A metabolomic study in C129S6 mice showed that feeding a HFD shifts the gut microbiota into a choline-degradation profile, resulting in low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines [27].”
BackgroundThe Gut Microbiota and Liver Disease
Llorente, C., & Schnabl, B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.003 · Cited by 190
Chronic Ethanol Consumption Alters Mammalian Gastrointestinal Content Metabolites
Xie, G., Zhong, W., Zheng, X., Li, Q., Qiu, Y., Li, H., Chen, H., Zhou, Z., & Jia, W. (2013) · Journal of Proteome Research · doi:10.1021/pr400362z · Cited by 137
The putative role of the intestinal microbiota in the irritable bowel syndrome
Collins, S. M., Denou, E., Verdu, E. F., & Berčík, P. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.023 · Cited by 133
Abdollahi‐Roodsaz, S., Abramson, S. B., & Scher, J. U. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.68 · Cited by 150
Zhao, L., Ni, Y., Su, M., Li, H., Dong, F., Chen, W., Wei, R., Zhang, L., Guiraud, S. P., Martin, F.-P., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00660 · Cited by 144
The struggle within: Microbial influences on colorectal cancer
Arthur, J. C., & Jobin, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21354 · Cited by 122
Carpi, R. Z., Barbalho, S. M., Sloan, K. P., Laurindo, L. F., Gonzaga, H. F., Grippa, P. C., Zutin, T. L. M., Gírio, R. J. S., Repetti, C. S. F., Detregiachi, C. R. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158805 · Cited by 155
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Han, H. L., Jiang, Y., Wang, M., Melaku, M., Liu, L., Zhao, Y. M., Everaert, N., Yi, B., & Zhang, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1966738 · Cited by 141
Loman, B. R., Hernández-Saavedra, D., An, R., & Rector, R. S. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy031 · Cited by 147
Dysbiosis in gastrointestinal disorders
Chang, C., & Lin, H. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.001 · Cited by 158
Walker, A., Pfitzner, B., Neschen, S., Kahle, M., Harir, M., Lucio, M., Moritz, F., Tziotis, D., Witting, M., Rothballer, M., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.79 · Cited by 129
“…changes occurring in metabolic diseases like obesity, are rarely given, but many studies addressed obesity-related metabolome characterization (Dumas et al., 2006; Williams et al., 2006; Fearnside et al., 2008; Li et al., 2008, 2010a; Shearer et al., 2008; Newgard et al., 2009; Waldram et…”
BackgroundEl Aidy, S., Merrifield, C. A., Derrien, M., van Baarlen, P., Hooiveld, G., Levenez, F., Doré, J., Dekker, J., Holmes, E., Claus, S. P., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301955 · Cited by 133
Self-citationSwann, J. R., Tuohy, K. M., Lindfors, P., Brown, D. T., Gibson, G. R., Wilson, I. D., Sidaway, J., Nicholson, J. K., & Holmes, E. (2011) · Journal of Proteome Research · doi:10.1021/pr200243t · Cited by 124
Self-citationBarton, R. H., Nicholson, J. K., Elliott, P., & Holmes, E. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym284 · Cited by 133
Self-citationThe Gut Microbiota and Nonalcoholic Fatty Liver Disease
Monsour, H., & Quigley, E. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562946 · Cited by 48
Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum
Wei, L., Liao, P., Wu, H., Li, X., Pei, F., Li, W., & Wu, Y. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.015 · Cited by 125
Wang, L., Zhang, H., Zhou, J.-Y., Liu, Y., Yang, Y., Chen, X., Zhu, C.-H., Zheng, R.-D., Ling, W., & Zhu, H. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.007 · Cited by 132
“HFD can reduce choline bioavailability for the host and mimic the choline-deficient diet contribution to NAFLD [34].”
BackgroundOral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice
Jin, C., Zeng, Z., Fu, Z., & Jin, Y. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.06.105 · Cited by 142
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
Suk, K. T., & Kim, D. J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1569513 · Cited by 149
Advances in NMR-based biofluid analysis and metabolite profiling
Zhang, S., Gowda, G. A. N., Ye, T., & Raftery, D. (2010) · In Analysis · doi:10.1039/c000091d · Cited by 120
A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model
Davidovic, L., Navratil, V., Bonaccorso, C. M., Catania, M. V., Bardoni, B., & Dumas, M.-E. (2011) · Genome Research · doi:10.1101/gr.116764.110 · Cited by 118
“2002), particularly in the case of metabolic diseases (Dumas et al. 2006; Dumas et al. 2007).”
BackgroundSelf-citationNutrition, inflammation and liver-spleen axis
Barrea, L., Di Somma, C., Muscogiuri, G., Tarantino, G., Tenore, G. C., Orio, F., Colao, A., & Savastano, S. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1353479 · Cited by 263
“As an alternative mechanism, gut microbiota on a high-fat diet may reduce the dietary choline bioavailability, an essential nutrient that is necessary for the secretion of very-low-density lipoprotein, thus promoting HS, IR and lipid peroxidation and inflammation (Dumas et al. 2006).”
BackgroundObesity and diabetes: from genetics to epigenetics
Burgio, E., Lopomo, A., & Migliore, L. (2015) · Molecular Biology Reports · doi:10.1007/s11033-014-3751-z · Cited by 168
Mencarelli, A., Cipriani, S., Renga, B., Bruno, A., D'Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 116
“Gut bacteria might contribute to the pathogenesis of liver inflammation by multiple mechanisms, including increasing gut luminal ethanol production [20], metabolizing dietary choline (required for verylow-density lipoprotein synthesis and hepatic lipid export) [21] and/or by releasing lipopolysaccharide [22] which is…”
BackgroundDiet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Machado, M., & Cortez-Pinto, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040481 · Cited by 123
“In su ar , gut microbiota can contribute to the develop ent and progression of FL via several ec a is s: ( ) l ti f r st sis r ar st fro diet ith associat obesit and dys etab lis [4,26]; (b) odulation of intestinal per eability pro oting en otoxe i as ell as ot er icr e ro cts t t ro t s st i ti i fl ti [ ]; (c) modul…”
BackgroundPhysiology and pathophysiology of liver lipid metabolism
Ponziani, F. R., Pecere, S., Gasbarrini, A., & Ojetti, V. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056156 · Cited by 147
“Notably, fatty liver is associated with disruption of choline metabolism, and cholinedeficient diets are used to reproduce NAFLD models [130,131].”
BackgroundDumas, M.-E., Rothwell, A. R., Hoyles, L., Aranias, T., Chilloux, J., Calderari, S., Noll, E. M., Péan, N., Boulangé, C. L., Blancher, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.039 · Cited by 114
“Methylamines (TMA, DMA, MMA, and TMAO) and their pre-cursor choline are the major metabolites associated with HFD in the C57BL/6J mouse (Figure 2D), which is consistent with our previous report (Dumas et al., 2006).”
BackgroundMethodResultInfluentialSelf-citationAbdul Rahim, M. B. H., Chilloux, J., Martinez-Gili, L., Neves, A. L., Myridakis, A., Gooderham, N., & Dumas, M.-E. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01312-x · Cited by 124
Self-citationMicrobial metabolites in health and disease: Navigating the unknown in search of function
Martinez, K. B., Leone, V., & Chang, E. B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.752899 · Cited by 132
“(55) found that microbial metabolism of choline to methylamines mimicked choline deficiency in the host, resulting in NAFLD.”
BackgroundRomick‐Rosendale, L. E., Goodpaster, A. M., Hanwright, P. J., Patel, N. B., Wheeler, E. T., Chona, D. L., & Kennedy, M. A. (2009) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.2511 · Cited by 108
Serum Metabolic Profiling in Inflammatory Bowel Disease
Williams, H. R. T., Willsmore, J., Cox, I. J., Walker, D. G., Cobbold, J., Taylor-Robinson, S. D., & Orchard, T. R. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2127-2 · Cited by 116
Phylometabonomic Patterns of Adaptation to High Fat Diet Feeding in Inbred Mice
Fearnside, J. F., Dumas, M.-E., Rothwell, A. R., Wilder, S. P., Cloarec, O., Toye, A., Blancher, C., Holmes, E., Tatoud, R., Barton, R. H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001668 · Cited by 106
“Evidence of dyslipidemia patterns, including increased PC level remained significantly associated with 129S6, as previously described in a gut microflora modulation context [31].”
BackgroundInfluentialSelf-citationThe Liver at the Nexus of Host-Microbial Interactions
Macpherson, A. J., Heikenwälder, M. F., & Ganal-Vonarburg, S. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.016 · Cited by 117
Gut microbial communities modulating brain development and function
Al-Asmakh, M., Anuar, F., Zadjali, F., Rafter, J., & Pettersson, S. (2012) · Gut Microbes · doi:10.4161/gmic.21287 · Cited by 117
“The influence of the microbiota extends beyond the gastrointestinal (GI) tract; contributing to, for example, pain perception in the skin(6) and fat deposition in the liver.(7,8) Disruption of the symbiotic relationship between the microbiota and the GI tract(9) perturbs host functions and, in some cases, will contrib…”
BackgroundBackshall, A., Sharma, R., Clarke, S. J., & Keun, H. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2474 · Cited by 112
“combination of pharmacogenetic and pharmacometabonomic information using up- and downstream data to help delineate the optimum therapeutic pathway for the individual patient (65, 66).”
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
“In addition, recent studies suggest TMAO levels may similarly be associated with the presence and severity of non-alcoholic fatty liver disease (18, 23, 24).”
BackgroundDysbiosis—A consequence of Paneth cell dysfunction
Salzman, N. H., & Bevins, C. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.09.006 · Cited by 132
The genetic architecture of NAFLD among inbred strains of mice
Hui, S. T., Parks, B. W., Org, E., Norheim, F., Che, N., Pan, C., Castellani, L. W., Charugundla, S., Dirks, D. L., Psychogios, N., et al. (2015) · eLife · doi:10.7554/elife.05607 · Cited by 104
“Previous results from studies of 129S6 mice, a model of diet-induced fatty liver disease, showed that TMANO was a marker for NAFLD (Dumas et al., 2006).”
BackgroundResultNASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages
Bieghs, V., Rensen, P. C. N., Hofker, M. H., & Shiri‐Sverdlov, R. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.041 · Cited by 108
“Likewise, the intestinal microbiota (gut flora), which serve as a filter for everything that we eat, have also an essential role in the development of complex metabolic abnormalities, such as insulin resistance, NASH and atherosclerosis [13,14].”
BackgroundRole of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 165
Xenobiotics: Interaction with the Intestinal Microflora
Lu, K., Mahbub, R., & Fox, J. G. (2015) · ILAR Journal · doi:10.1093/ilar/ilv018 · Cited by 117
“Another major disease in which the GM is implicated is nonalcoholic fatty liver disease (NAFLD).”
BackgroundInfluentialToye, A. A., Dumas, M., Blancher, C., Rothwell, A. R., Fearnside, J., Wilder, S. P., Bihoreau, M., Cloarec, O., Azzouzi, I., Young, S., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0738-5 · Cited by 110
“We have used global functional genomic approaches to document the impact of dietary changes on the regulation of gene expression in an inbred mouse strain susceptible to HFD-induced obesity, diabetes and NAFLD [13, 14 ].”
BackgroundMethodResultInfluentialSelf-citationMetabotyping of Caenorhabditis elegans reveals latent phenotypes
Blaise, B. J., Giacomotto, J., Elena, B., Dumas, M.-E., Toulhoat, P., Ségalat, L., & Emsley, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707393104 · Cited by 109
Self-citationNishitsuji, K., Xiao, J., Nagatomo, R., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., & Tsuneyama, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-16189-5 · Cited by 118
Progress in genomics, metabolism and biotechnology of bifidobacteria
Cronin, M. A., Ventura, M., Fitzgerald, G. F., & van Sinderen, D. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.01.019 · Cited by 104
Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice
Jo, J.-K., Seo, S.-H., Park, S.-E., Kim, H., Kim, E., Kim, J.-S., Pyo, J., Cho, K., Kwon, S.-J., Park, D.-H., et al. (2021) · Metabolites · doi:10.3390/metabo11080482 · Cited by 124
“High-throughput analytical platforms, such as gas chromatography mass spectrometry (GC-MS), have recently been used to improve our understanding of disease processes [15], biomarker discovery [16], and especially, microbiome-host interactions [17,18].”
BackgroundRudzki, L., Stone, T. W., Maes, M. H. J., Misiak, B., Samochowiec, J., & Szulc, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110240 · Cited by 153
Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease
Stärkel, P., & Schnabl, B. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1593882 · Cited by 108
Cao, H., Huang, H., Xu, W., Chen, D., Yu, J., Li, J., & Li, L. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.02.038 · Cited by 115
Teng, M., Zhu, W., Wang, D., Qi, S., Wang, Y., Yan, J., Dong, K., Zheng, M., & Wang, C. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.11.009 · Cited by 122
“Moreover, an increase in dimethylamine was shown to affect the histopathology of insulin-resistant mice (Dumas et al., 2006).”
BackgroundThe colonic microbiota in health and disease
Shanahan, F. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a3493 · Cited by 102
“Unaut 0267-1379 2012 Wolters Kluwer Health | Lippincott Williams & Wilk converts dietary phosphatidylcholine to metabolites that contribute to hepatic steatosis in mice [46] and to human atherosclerosis [47 && ].”
BackgroundZeisel, S. H. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.542 · Cited by 106
“For example, metabolomic analyses showed that the altered availability of choline caused by metabolism by gut microflora was associated with fatty liver in insulin-resistant mice (51).”
BackgroundSmith, L., Villaret, J., Claus, S. P., Canlet, C., Guillou, H., Cabaton, N. J., & Ellero‐Simatos, S. (2020) · Metabolites · doi:10.3390/metabo10030104 · Cited by 133
“Among others, these include: Non-invasive biomarker investigations to discriminate between the different stages of progression of NAFLD using non-invasive biofluids (urine and plasma) [3,4]; investigation of mechanisms underlying hepatic disease progression such as acute-on-chronic liver failure using serum metabolic…”
BackgroundCoordinated regulation of the metabolome and lipidome at the host-microbial interface
Bäckhed, F., & Crawford, P. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.009 · Cited by 90
“The metabolic significance of the ability of the microbiome to influence phosphatidylcholine metabolism was demonstrated by the use of proton NMR-based metabolomics [42].”
Martin, F. J., Wang, Y., Sprenger, N., Yap, I. K. S., Rezzi, S., Ramadan, Z., Peré‐Trepat, E., Rochat, F., Cherbut, C., van Bladeren, P., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.40 · Cited by 91
“…calorific bioavailability via differential metabolism of bile acids, andwe and others have surmised that related metabolic processes might be involved in common metabolic diseases such as obesity or type II diabetes (Dumas et al, 2006; Houten et al, 2006; Watanabe et al, 2006; Martin et al, 2007a).”
BackgroundSelf-citationYan, S.-K., Wei, B.-J., Lin, Z.-Y., Yang, Y., Zhou, Z.-T., & Zhang, W.-D. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.06.007 · Cited by 95
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.005 · Cited by 103
“Metagenomic approaches help recognize biochemical processes, me tabolic conditions in non–insulin dependent diabetes, nonalcoholic steatosis, and ath erosclerosis linking the changes to the microbial population (50) and this data can be inte rpreted by using the bioinformatics methods and also predict the metabolic in…”
MethodFar from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences
Serino, M., Blasco-Baque, V., Nicolas, S., & Burcelin, R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0540-1 · Cited by 93
New tricks for the glycyl radical enzyme family
Backman, L. R. F., Funk, M. A., Dawson, C. D., & Drennan, C. L. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1373741 · Cited by 108
“…with chronic kidney disease (Bammens et al. 2006; Poveda et al. 2014), and CutC activity has been linked to nonalcoholic fatty liver disease (Dumas et al. 2006), cardiovascular disease (Wang et al. 2011; Tang et al. 2013) and trimethylaminuria (fish malodor syndrome) (Christodoulou 2012).”
Systems biology of host–microbe metabolomics
Heinken, A., & Thiele, I. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1301 · Cited by 101
London, L. E. E., Kumar, A. H. S., Wall, R., Casey, P. G., O’Sullivan, Ó., Shanahan, F., Hill, C., Cotter, P. D., Fitzgerald, G. F., Ross, R. P., et al. (2014) · Journal of Nutrition · doi:10.3945/jn.114.191627 · Cited by 113
“The human intestinal microbiota has been implicated in the development of obesity (2), insulin resistance (3), and more recently, CVD risk (4, 5).”
BackgroundDrugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring
Wilson, I. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907721106 · Cited by 88
Patterns and Scales in Gastrointestinal Microbial Ecology
Camp, J. G., Kanther, M., Semova, I., & Rawls, J. F. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.075 · Cited by 86
Endotoxins and Non-Alcoholic Fatty Liver Disease
Kessoku, T., Kobayashi, T., Imajo, K., Tanaka, K., Yamamoto, A., Takahashi, K., Kasai, Y., Ozaki, A., Iwaki, M., Nogami, A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770986 · Cited by 113
Gut microbiota as important modulator of metabolism in health and disease
Wang, X., Zhang, A., Miao, J.-H., Sun, H. J., Yan, G., Wu, F., & Wang, X.-J. (2018) · RSC Advances · doi:10.1039/c8ra08094a · Cited by 117
Gut Microbiota and Lifestyle Interventions in NAFLD
Houghton, D., Stewart, C. J., Day, C. P., & Trenell, M. I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040447 · Cited by 114
“High fat diets have also been shown to modulate the levels of Gammaproteobacteria and Erysipelotrichi, which have been shown to lead to choline deficiency, liver fat accumulation and NASH [65,92–94].”
BackgroundLade, A., Noon, L. A., & Friedman, S. L. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000042 · Cited by 100
“The gut microbiota play a key role in the development of obesity, insulin resistance, and NAFLD by: affecting caloric extraction from the diet and the bioavailability of essential nutrients such as choline [31]; activation of TLRs and inflammation in the gut, the vasculature, and the liver; and production of alcohol,…”
BackgroundCord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes
Orešič, M., Gopalacharyulu, P., Mykkänen, J., Lietzen, N., Mäkinen, M., Nygren, H., Simell, S., Simell, V., Hyöty, H., Veijola, R., et al. (2013) · Diabetes · doi:10.2337/db13-0159 · Cited by 88
“Although dietary supplementation has mainly been considered as a way to increase the levels of choline, other factors affecting the choline metabolism such as gut microbiota (35) may also need to be considered in order to optimize the utilization of dietary choline.”
BackgroundMetabolomics-on-a-Chip and Predictive Systems Toxicology in Microfluidic Bioartificial Organs
Shintu, L., Baudoin, R., Navratil, V., Prot, J.-M., Pontoizeau, C., Defernez, M., Blaise, B. J., Domange, C., Péry, A. R., Toulhoat, P., et al. (2012) · Analytical Chemistry · doi:10.1021/ac2011075 · Cited by 100
Self-citationGut Microbiota: A Contributing Factor to Obesity
Harakeh, S. M., Khan, I., Kumosani, T., Barbour, E., Almasaudi, S. B., Bahijri, S. M., Alfadul, S. M., Ajabnoor, G. M. A., & Azhar, E. I. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00095 · Cited by 107
“Advanced analytical platforms such as metagenomics and metabolomics, revealed that GM help host in harvesting energy and lead to increasing adiposity (Dumas et al., 2006; Martin et al., 2008; Turnbaugh et al., 2008; Turnbaugh and Gordon, 2009).”
BackgroundNishitsuji, K., Watanabe, S., Xiao, J., Nagatomo, R., Ogawa, H., Tsunematsu, T., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34571-9 · Cited by 90
Microbial metabolites in non-alcoholic fatty liver disease
Zhou, D., & Fan, J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2019 · Cited by 106
Janssen, A. W. F., Houben, T., Katiraei, S., Dijk, W., Boutens, L., van der Bolt, N., Wang, Z., Brown, J. M., Hazen, S. L., Mandard, S., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075713 · Cited by 122
“TMA has been linked to NAFLD by reflecting the microbial conversion and depletion of choline (49).”
BackgroundHe, J., Li, G., Chen, J., Lin, J., Zeng, C. C., Chen, J., Deng, J., & Xie, P. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1681-3 · Cited by 104
From the stomach to other organs:Helicobacter pyloriand the liver
Waluga, M., Kukla, M., Żorniak, M., Bacik, A., & Kotulski, R. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i18.2136 · Cited by 97
Zeng, H., Liu, J., Jackson, M. I., Zhao, F., Yan, L., & Combs, G. F. (2013) · Journal of Nutrition · doi:10.3945/jn.112.172460 · Cited by 97
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie, C., & Halegoua-DeMarzio, D. L. (2019) · Nutrients · doi:10.3390/nu11112837 · Cited by 107
“TMAO also increases insulin resistance, promotes inflammation and oxidative stress [71,72].”
Background
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.